Receptor for Advanced Glycation Endproducts mediates proatherogenic responses to periodontal infection in vascular endothelial cells

Objective— A link between periodontal infections and an increased risk for vascular disease has been demonstrated. Porphyromonas gingivalis , a major periodontal pathogen, localizes in human atherosclerotic plaques, accelerates atherosclerosis in animal models and modulates vascular cell function. The receptor for advanced glycation endproducts (RAGE) regulates vascular inflammation and atherogenesis. We hypothesized that RAGE is involved in P. gingivalis ’s contribution to proatherogenic responses in vascular endothelial cells. Methods and Results— Murine aortic endothelial cells (MAEC) were isolated from wild type C57BL/6 or RAGE − / − mice and were infected with P. gingivalis strain 381. P. gingivalis 381 infection significantly enhanced expression of RAGE in wild-type MAEC. Levels of proatherogenic advanced glycation endproducts (AGEs) and monocyte chemoattractant protein 1 (MCP-1) were significantly increased in wild-type MAEC following P. gingivalis 381 infection, but were unaffected in MAEC from RAGE − / − mice or in MAEC infected with DPG3, a fimbriae-deficient mutant of P. gingivalis 381. Consistent with a role for oxidative stress and an AGE-dependent activation of RAGE in this setting, both antioxidant treatment and AGE blockade significantly suppressed RAGE gene expression and RAGE and MCP-1 protein levels in P. gingivalis 381 infected human aortic endothelial cells (HAEC). Conclusion— The present findings implicate for the first time the AGE-RAGE axis in the amplification of proatherogenic responses triggered by P. gingivalis in vascular endothelial cells.

[1]  F. C. Gibson,et al.  Innate Immune Recognition of Invasive Bacteria Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice , 2004, Circulation.

[2]  H. Kuramitsu,et al.  Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. , 2002, FEMS immunology and medical microbiology.

[3]  Y. Zou,et al.  Oxygen Deprivation Triggers Upregulation of Early Growth Response-1 by the Receptor for Advanced Glycation End Products , 2008, Circulation research.

[4]  T. Kodama,et al.  A simple method of isolating mouse aortic endothelial cells. , 2005, Journal of atherosclerosis and thrombosis.

[5]  C. Skoglund,et al.  The periodontal pathogen Porphyromonas gingivalis cleaves apoB‐100 and increases the expression of apoM in LDL in whole blood leading to cell proliferation , 2008, Journal of internal medicine.

[6]  P. Papapanou,et al.  Oral Infection With a Periodontal Pathogen Accelerates Early Atherosclerosis in Apolipoprotein E–Null Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Papapanou,et al.  Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. , 2007, Atherosclerosis.

[8]  A. Schmidt,et al.  Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts , 1998, Nature Medicine.

[9]  D. Graves,et al.  A role for advanced glycation end products in diminished bone healing in type 1 diabetes. , 2003, Diabetes.

[10]  W. Ketterl [Periodontal diseases]. , 1971, Der Zahnarzt; Colloquium med. dent.

[11]  C. E. Taylor,et al.  Potential infectious etiologies of atherosclerosis: a multifactorial perspective. , 2001, Emerging infectious diseases.

[12]  R. Ramasamy,et al.  Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. , 2008, The Journal of clinical investigation.

[13]  T. Kislinger,et al.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. , 2000, The Journal of clinical investigation.

[14]  R. de Caterina,et al.  Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses , 2002, Circulation.

[15]  P. Papapanou,et al.  Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells , 2006, Journal of thrombosis and haemostasis : JTH.

[16]  S. Moncada,et al.  Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: A new insight into selective nitrergic neuropathy in diabetes , 2004, Diabetologia.

[17]  M. Cooper,et al.  The role of AGEs in cardiovascular disease. , 2008, Current pharmaceutical design.

[18]  Li Lin RAGE on the Toll Road? , 2006, Cellular & molecular immunology.

[19]  J. Beck,et al.  The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. , 2001, Annals of periodontology.

[20]  P. Papapanou,et al.  Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells. , 2009, Thrombosis research.

[21]  G. Koch,et al.  Porphyromonas gingivalis Bacteremia Induces Coronary and Aortic Atherosclerosis in Normocholesterolemic and Hypercholesterolemic Pigs , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[22]  D. Kinane,et al.  Bacteraemia following periodontal procedures , 2005, Journal of clinical periodontology.

[23]  H. Kuramitsu,et al.  Role for periodontal bacteria in cardiovascular diseases. , 2001, Annals of periodontology.

[24]  A. Progulske-Fox,et al.  Invasion of Human Coronary Artery Cells by Periodontal Pathogens , 1999, Infection and Immunity.

[25]  G. Bagby,et al.  Importance of TLR2 in Early Innate Immune Response to Acute Pulmonary Infection with Porphyromonas gingivalis in Mice1 , 2008, The Journal of Immunology.

[26]  W. Hurley,et al.  Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. , 1992, The Journal of biological chemistry.